IN192188B - - Google Patents

Info

Publication number
IN192188B
IN192188B IN596DE2000A IN192188B IN 192188 B IN192188 B IN 192188B IN 596DE2000 A IN596DE2000 A IN 596DE2000A IN 192188 B IN192188 B IN 192188B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Pant Abha
Bhatia Inderdeep
Roy S Bhushan
Malik Rajiv
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN596DE2000 priority Critical patent/IN192188B/en
Priority to BR0106752-4A priority patent/BR0106752A/pt
Priority to JP2002510065A priority patent/JP2004503493A/ja
Priority to EA200200166A priority patent/EA004808B1/ru
Priority to EP01917381A priority patent/EP1294357A1/en
Priority to APAP/P/2002/002423A priority patent/AP2002002423A0/en
Priority to PCT/IB2001/000581 priority patent/WO2001095886A1/en
Priority to SK225-2002A priority patent/SK2252002A3/sk
Priority to HU0203717A priority patent/HUP0203717A3/hu
Priority to US09/829,246 priority patent/US6740337B2/en
Priority to MXPA02001669A priority patent/MXPA02001669A/es
Priority to OA1200200055A priority patent/OA12008A/fr
Priority to IL14817601A priority patent/IL148176A0/xx
Priority to CA002382065A priority patent/CA2382065A1/en
Priority to PL01352838A priority patent/PL352838A1/xx
Priority to NZ517142A priority patent/NZ517142A/en
Priority to EEP200200074A priority patent/EE200200074A/xx
Priority to CNB018024173A priority patent/CN1196475C/zh
Priority to CZ2002694A priority patent/CZ2002694A3/cs
Priority to AU44459/01A priority patent/AU782094B2/en
Priority to UA2002031946A priority patent/UA74793C2/uk
Priority to ZA200201240A priority patent/ZA200201240B/en
Priority to BG06414A priority patent/BG106414A/xx
Priority to HR20020148A priority patent/HRP20020148A2/hr
Priority to HK03104641.2A priority patent/HK1052302A1/zh
Publication of IN192188B publication Critical patent/IN192188B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN596DE2000 2000-06-16 2000-06-16 IN192188B (sl)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IN596DE2000 IN192188B (sl) 2000-06-16 2000-06-16
BR0106752-4A BR0106752A (pt) 2000-06-16 2001-04-09 Forma biodisponìvel de dosagem de isotretinoìna
JP2002510065A JP2004503493A (ja) 2000-06-16 2001-04-09 イソトレチノインの生物学的有効投与形態
EA200200166A EA004808B1 (ru) 2000-06-16 2001-04-09 Биодоступная лекарственная форма изотретиноина
EP01917381A EP1294357A1 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
APAP/P/2002/002423A AP2002002423A0 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin.
PCT/IB2001/000581 WO2001095886A1 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
SK225-2002A SK2252002A3 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin and process for producing thereof
HU0203717A HUP0203717A3 (en) 2000-06-16 2001-04-09 Bioavailable composition containing isotretinoin and process for its preparation
US09/829,246 US6740337B2 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
MXPA02001669A MXPA02001669A (es) 2000-06-16 2001-04-09 Forma de dosificacion biodisponible de isotretinoin.
OA1200200055A OA12008A (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin.
IL14817601A IL148176A0 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
CA002382065A CA2382065A1 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
PL01352838A PL352838A1 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
NZ517142A NZ517142A (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
EEP200200074A EE200200074A (et) 2000-06-16 2001-04-09 Isotretinoiini biosaadav annustamisvorm
CNB018024173A CN1196475C (zh) 2000-06-16 2001-04-09 异维甲酸的生物可利用剂型
CZ2002694A CZ2002694A3 (cs) 2000-06-16 2001-04-09 Biodostupná dávková forma isotretinoinu
AU44459/01A AU782094B2 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin
UA2002031946A UA74793C2 (en) 2000-06-16 2001-09-04 Bioavailable pharmaceutical composition of isotretinoin and process for preparing such composition
ZA200201240A ZA200201240B (en) 2000-06-16 2002-02-13 Bioavailable dosage form of isotretinoin.
BG06414A BG106414A (en) 2000-06-16 2002-02-14 Bioavailable dosage form of isotretinoin
HR20020148A HRP20020148A2 (en) 2000-06-16 2002-02-15 Bioavailable dosage of isotretinoin
HK03104641.2A HK1052302A1 (zh) 2000-06-16 2003-06-30 異維甲酸的生物可利用劑型

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN596DE2000 IN192188B (sl) 2000-06-16 2000-06-16

Publications (1)

Publication Number Publication Date
IN192188B true IN192188B (sl) 2004-03-13

Family

ID=11097063

Family Applications (1)

Application Number Title Priority Date Filing Date
IN596DE2000 IN192188B (sl) 2000-06-16 2000-06-16

Country Status (25)

Country Link
US (1) US6740337B2 (sl)
EP (1) EP1294357A1 (sl)
JP (1) JP2004503493A (sl)
CN (1) CN1196475C (sl)
AP (1) AP2002002423A0 (sl)
AU (1) AU782094B2 (sl)
BG (1) BG106414A (sl)
BR (1) BR0106752A (sl)
CA (1) CA2382065A1 (sl)
CZ (1) CZ2002694A3 (sl)
EA (1) EA004808B1 (sl)
EE (1) EE200200074A (sl)
HK (1) HK1052302A1 (sl)
HR (1) HRP20020148A2 (sl)
HU (1) HUP0203717A3 (sl)
IL (1) IL148176A0 (sl)
IN (1) IN192188B (sl)
MX (1) MXPA02001669A (sl)
NZ (1) NZ517142A (sl)
OA (1) OA12008A (sl)
PL (1) PL352838A1 (sl)
SK (1) SK2252002A3 (sl)
UA (1) UA74793C2 (sl)
WO (1) WO2001095886A1 (sl)
ZA (1) ZA200201240B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2423170A1 (en) * 2000-09-22 2002-03-28 Galephar M/F Pharmaceutical semi-solid composition of isotretinoin
EP1527774A1 (en) 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
MXPA05012632A (es) * 2003-05-20 2006-02-22 Ranbaxy Lab Ltd Composiciones farmaceuticas de acitretin.
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
EP2123255B1 (en) * 2007-02-16 2013-05-15 ASKA Pharmaceutical Co., Ltd. Pharmaceutical composition containing fine particle oil-based suspension
US7763748B2 (en) * 2007-02-20 2010-07-27 Ipca Laboratories Limited Process for preparation of highly pure isotretinoin
US9078925B2 (en) 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
MX2017015137A (es) * 2015-05-25 2018-03-28 Sun Pharmaceutical Ind Ltd Composicion farmaceutica oral de dosis diaria de isotretinoin.
WO2017203365A1 (en) 2016-05-26 2017-11-30 Dr. Reddy's Laboratiories Ltd. Pharmaceutical compositions for treating acne

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US4808630A (en) * 1987-01-16 1989-02-28 United States Of America Method of treating psychotic illnesses
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
PE20001227A1 (es) 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof

Also Published As

Publication number Publication date
AU782094B2 (en) 2005-06-30
ZA200201240B (en) 2002-09-02
CZ2002694A3 (cs) 2002-08-14
AP2002002423A0 (en) 2002-03-31
PL352838A1 (en) 2003-09-08
CN1196475C (zh) 2005-04-13
HUP0203717A3 (en) 2003-05-28
HUP0203717A2 (hu) 2003-04-28
IL148176A0 (en) 2002-09-12
US20020025338A1 (en) 2002-02-28
BG106414A (en) 2002-09-30
EP1294357A1 (en) 2003-03-26
EE200200074A (et) 2003-04-15
US6740337B2 (en) 2004-05-25
BR0106752A (pt) 2002-04-16
JP2004503493A (ja) 2004-02-05
NZ517142A (en) 2003-08-29
CA2382065A1 (en) 2001-12-20
MXPA02001669A (es) 2002-08-06
OA12008A (en) 2006-04-19
HK1052302A1 (zh) 2003-09-11
HRP20020148A2 (en) 2003-12-31
EA004808B1 (ru) 2004-08-26
EA200200166A1 (ru) 2002-10-31
UA74793C2 (en) 2006-02-15
AU4445901A (en) 2001-12-24
WO2001095886A1 (en) 2001-12-20
CN1388757A (zh) 2003-01-01
SK2252002A3 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
BE2014C019I2 (sl)
BE2013C048I2 (sl)
BE2012C016I2 (sl)
JP2003524467A5 (sl)
BRPI0113085B8 (sl)
AU2000236815A8 (sl)
JP2001338486A5 (sl)
JP2003527621A5 (sl)
JP2003503716A5 (sl)
JP2001192805A5 (sl)
AR028236A3 (sl)
BE2010C040I2 (sl)
JP2001157241A5 (sl)
IN192188B (sl)
JP2001232906A5 (sl)
JP2001210106A5 (sl)
CH694022C1 (sl)
JP2002158917A5 (sl)
JP2002169120A5 (sl)
JP2002177528A5 (sl)
CN3145693S (sl)
CN3144584S (sl)
CN3141567S (sl)
AU2000278560A8 (sl)
CN3141437S (sl)